| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hernias, Diaphragmatic, Congenital | 6 | 2024 | 399 | 1.680 |
Why?
|
| Infant, Very Low Birth Weight | 4 | 2024 | 171 | 0.900 |
Why?
|
| Respiratory System Abnormalities | 1 | 2020 | 42 | 0.680 |
Why?
|
| Birth Weight | 4 | 2020 | 346 | 0.610 |
Why?
|
| Hypoglycemia | 1 | 2020 | 189 | 0.590 |
Why?
|
| Infant, Premature, Diseases | 14 | 2024 | 242 | 0.570 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2020 | 610 | 0.520 |
Why?
|
| Mass Screening | 1 | 2020 | 782 | 0.440 |
Why?
|
| Infant, Newborn | 38 | 2024 | 8187 | 0.440 |
Why?
|
| Bacteremia | 2 | 2008 | 407 | 0.350 |
Why?
|
| Infant, Low Birth Weight | 12 | 1995 | 167 | 0.350 |
Why?
|
| Trachea | 3 | 2024 | 202 | 0.300 |
Why?
|
| Gram-Negative Bacteria | 1 | 2008 | 68 | 0.300 |
Why?
|
| Neonatal Screening | 3 | 2020 | 184 | 0.300 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2008 | 87 | 0.290 |
Why?
|
| Bilirubin | 2 | 2020 | 122 | 0.290 |
Why?
|
| Fetoscopy | 3 | 2024 | 448 | 0.250 |
Why?
|
| Biliary Atresia | 2 | 2020 | 190 | 0.240 |
Why?
|
| Urine Specimen Collection | 1 | 2022 | 3 | 0.210 |
Why?
|
| Specimen Handling | 1 | 2022 | 142 | 0.190 |
Why?
|
| Airway Obstruction | 1 | 2023 | 165 | 0.180 |
Why?
|
| Cerebral Hemorrhage | 8 | 1996 | 140 | 0.180 |
Why?
|
| Asymptomatic Diseases | 1 | 2020 | 83 | 0.160 |
Why?
|
| Portoenterostomy, Hepatic | 1 | 2020 | 49 | 0.160 |
Why?
|
| Blood | 1 | 2000 | 104 | 0.160 |
Why?
|
| Bacteriological Techniques | 1 | 2000 | 87 | 0.160 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2000 | 95 | 0.160 |
Why?
|
| Catheterization, Central Venous | 1 | 2020 | 131 | 0.150 |
Why?
|
| Gestational Age | 5 | 2020 | 1158 | 0.150 |
Why?
|
| Catheterization, Peripheral | 1 | 2020 | 125 | 0.150 |
Why?
|
| Retrospective Studies | 9 | 2024 | 16323 | 0.150 |
Why?
|
| Humans | 44 | 2024 | 124693 | 0.140 |
Why?
|
| Positive-Pressure Respiration | 1 | 1998 | 82 | 0.140 |
Why?
|
| Anuria | 1 | 2017 | 13 | 0.140 |
Why?
|
| Myotonic Dystrophy | 1 | 1998 | 149 | 0.130 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2017 | 136 | 0.130 |
Why?
|
| Prognosis | 3 | 2024 | 4622 | 0.120 |
Why?
|
| Oxygen | 1 | 2017 | 553 | 0.110 |
Why?
|
| Immunization, Passive | 2 | 1990 | 120 | 0.100 |
Why?
|
| Texas | 4 | 2020 | 3584 | 0.100 |
Why?
|
| Pregnancy | 7 | 2024 | 7171 | 0.100 |
Why?
|
| Cross Infection | 4 | 1999 | 323 | 0.100 |
Why?
|
| Female | 20 | 2024 | 66548 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2020 | 3447 | 0.090 |
Why?
|
| Infection Control | 2 | 1999 | 155 | 0.090 |
Why?
|
| Agammaglobulinemia | 1 | 1990 | 40 | 0.080 |
Why?
|
| Hypoplastic Left Heart Syndrome | 3 | 1999 | 252 | 0.080 |
Why?
|
| Kidney | 1 | 2017 | 1356 | 0.080 |
Why?
|
| Staphylococcal Infections | 3 | 2009 | 558 | 0.080 |
Why?
|
| Male | 20 | 2024 | 61257 | 0.080 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 2153 | 0.080 |
Why?
|
| Fatty Alcohols | 3 | 1995 | 5 | 0.080 |
Why?
|
| Phosphorylcholine | 3 | 1995 | 26 | 0.080 |
Why?
|
| Intubation, Intratracheal | 2 | 2024 | 290 | 0.070 |
Why?
|
| Pulmonary Surfactants | 3 | 1995 | 43 | 0.070 |
Why?
|
| Polyethylene Glycols | 3 | 1995 | 225 | 0.070 |
Why?
|
| Adjuvants, Immunologic | 1 | 2008 | 381 | 0.070 |
Why?
|
| Intensive Care Units, Neonatal | 3 | 1999 | 314 | 0.060 |
Why?
|
| Infant | 7 | 2024 | 12471 | 0.060 |
Why?
|
| Indomethacin | 3 | 1996 | 84 | 0.060 |
Why?
|
| Hyaline Membrane Disease | 2 | 1982 | 4 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2020 | 2050 | 0.060 |
Why?
|
| Airway Management | 1 | 2024 | 66 | 0.060 |
Why?
|
| Surface-Active Agents | 1 | 2024 | 33 | 0.060 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2023 | 968 | 0.060 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 4 | 1995 | 79 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2009 | 1018 | 0.050 |
Why?
|
| Lung Volume Measurements | 1 | 2023 | 75 | 0.050 |
Why?
|
| Incidence | 3 | 2008 | 3140 | 0.050 |
Why?
|
| Prenatal Care | 2 | 2023 | 347 | 0.050 |
Why?
|
| Ductus Arteriosus, Patent | 3 | 1996 | 144 | 0.050 |
Why?
|
| Umbilical Veins | 1 | 2020 | 73 | 0.040 |
Why?
|
| Drug Administration Schedule | 2 | 2000 | 721 | 0.040 |
Why?
|
| Short Bowel Syndrome | 1 | 1999 | 65 | 0.040 |
Why?
|
| Palliative Care | 3 | 1999 | 428 | 0.040 |
Why?
|
| Reference Values | 1 | 2020 | 710 | 0.040 |
Why?
|
| Catheterization | 1 | 2020 | 233 | 0.040 |
Why?
|
| Immunoglobulins | 2 | 1990 | 171 | 0.040 |
Why?
|
| Influenza A virus | 1 | 1999 | 138 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 186 | 0.040 |
Why?
|
| Interprofessional Relations | 1 | 1999 | 143 | 0.040 |
Why?
|
| Ventilator Weaning | 1 | 1998 | 23 | 0.040 |
Why?
|
| Syphilis, Congenital | 1 | 1998 | 28 | 0.040 |
Why?
|
| Serratia Infections | 1 | 1997 | 4 | 0.040 |
Why?
|
| Serratia marcescens | 1 | 1997 | 10 | 0.040 |
Why?
|
| Empyema, Pleural | 1 | 1997 | 25 | 0.040 |
Why?
|
| Prospective Studies | 5 | 2000 | 6147 | 0.040 |
Why?
|
| Nose | 1 | 1998 | 93 | 0.040 |
Why?
|
| Risk Factors | 3 | 2008 | 10281 | 0.030 |
Why?
|
| Disease Outbreaks | 2 | 1996 | 320 | 0.030 |
Why?
|
| Decision Making | 2 | 1999 | 655 | 0.030 |
Why?
|
| Pneumonia, Bacterial | 1 | 1997 | 76 | 0.030 |
Why?
|
| Pneumothorax | 1 | 1997 | 77 | 0.030 |
Why?
|
| Lipids | 1 | 2020 | 514 | 0.030 |
Why?
|
| Premedication | 1 | 1996 | 43 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2017 | 237 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1996 | 64 | 0.030 |
Why?
|
| Streptococcus pyogenes | 1 | 1996 | 76 | 0.030 |
Why?
|
| Neurologic Examination | 3 | 1995 | 193 | 0.030 |
Why?
|
| Bone and Bones | 1 | 1998 | 266 | 0.030 |
Why?
|
| Infant, Premature | 4 | 1997 | 812 | 0.030 |
Why?
|
| Resource Allocation | 1 | 1996 | 52 | 0.030 |
Why?
|
| Respiratory Insufficiency | 1 | 1998 | 226 | 0.030 |
Why?
|
| Double-Blind Method | 5 | 2009 | 1640 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2024 | 12353 | 0.030 |
Why?
|
| Bronchopulmonary Dysplasia | 3 | 1996 | 191 | 0.030 |
Why?
|
| Lung | 1 | 2023 | 1490 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 568 | 0.030 |
Why?
|
| Disclosure | 1 | 1996 | 151 | 0.030 |
Why?
|
| Retinal Diseases | 3 | 1982 | 171 | 0.030 |
Why?
|
| Liver Abscess | 1 | 1994 | 12 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 1999 | 663 | 0.030 |
Why?
|
| Streptococcal Infections | 1 | 1996 | 243 | 0.030 |
Why?
|
| Ganciclovir | 1 | 1994 | 103 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 2819 | 0.030 |
Why?
|
| Influenza, Human | 1 | 1999 | 658 | 0.030 |
Why?
|
| Health Status | 1 | 1995 | 375 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 1996 | 395 | 0.030 |
Why?
|
| Candidiasis | 1 | 1994 | 129 | 0.030 |
Why?
|
| Child Development | 1 | 1995 | 267 | 0.020 |
Why?
|
| Dexamethasone | 1 | 1994 | 276 | 0.020 |
Why?
|
| Adenoviruses, Human | 1 | 1992 | 81 | 0.020 |
Why?
|
| Adenovirus Infections, Human | 1 | 1992 | 50 | 0.020 |
Why?
|
| Cytomegalovirus Infections | 1 | 1994 | 219 | 0.020 |
Why?
|
| Escherichia coli Infections | 1 | 1994 | 195 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2020 | 1038 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 3430 | 0.020 |
Why?
|
| Time Factors | 2 | 2000 | 6308 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 2 | 2000 | 2428 | 0.020 |
Why?
|
| Drug Combinations | 4 | 1995 | 268 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 1990 | 275 | 0.020 |
Why?
|
| Retinopathy of Prematurity | 2 | 1995 | 57 | 0.020 |
Why?
|
| Biomarkers | 1 | 2017 | 3066 | 0.020 |
Why?
|
| Virus Diseases | 1 | 1990 | 280 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 1990 | 270 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 1996 | 1116 | 0.020 |
Why?
|
| Heart Transplantation | 3 | 1999 | 855 | 0.020 |
Why?
|
| Counseling | 2 | 1999 | 217 | 0.020 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 1986 | 93 | 0.020 |
Why?
|
| Dipeptidases | 1 | 1985 | 14 | 0.020 |
Why?
|
| Thienamycins | 1 | 1985 | 14 | 0.020 |
Why?
|
| Cyclopropanes | 1 | 1985 | 68 | 0.010 |
Why?
|
| Follow-Up Studies | 4 | 1995 | 5158 | 0.010 |
Why?
|
| DNA, Viral | 2 | 1999 | 480 | 0.010 |
Why?
|
| Education, Special | 1 | 1983 | 11 | 0.010 |
Why?
|
| Disabled Persons | 1 | 1983 | 94 | 0.010 |
Why?
|
| Social Class | 1 | 1983 | 190 | 0.010 |
Why?
|
| Multivariate Analysis | 2 | 1996 | 1435 | 0.010 |
Why?
|
| Intermittent Positive-Pressure Ventilation | 1 | 1982 | 8 | 0.010 |
Why?
|
| Vitamin E | 1 | 1981 | 67 | 0.010 |
Why?
|
| Methicillin | 1 | 1981 | 43 | 0.010 |
Why?
|
| Cerebral Palsy | 1 | 1982 | 79 | 0.010 |
Why?
|
| Infant, Small for Gestational Age | 1 | 1980 | 57 | 0.010 |
Why?
|
| Spasms, Infantile | 1 | 1982 | 171 | 0.010 |
Why?
|
| Adult | 2 | 1998 | 29473 | 0.010 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1999 | 113 | 0.010 |
Why?
|
| Hospitals, Urban | 1 | 1999 | 99 | 0.010 |
Why?
|
| Nasopharynx | 1 | 1999 | 79 | 0.010 |
Why?
|
| Hydrocephalus | 1 | 1982 | 242 | 0.010 |
Why?
|
| Neonatology | 1 | 1999 | 53 | 0.010 |
Why?
|
| Injections, Intravenous | 2 | 1990 | 254 | 0.010 |
Why?
|
| Drug Evaluation | 2 | 1990 | 107 | 0.010 |
Why?
|
| Hypercapnia | 1 | 1978 | 20 | 0.010 |
Why?
|
| Osteomyelitis | 1 | 1981 | 206 | 0.010 |
Why?
|
| Quality of Life | 2 | 1999 | 1935 | 0.010 |
Why?
|
| Surveys and Questionnaires | 2 | 1999 | 3716 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 1981 | 460 | 0.010 |
Why?
|
| Child, Preschool | 2 | 1983 | 14013 | 0.010 |
Why?
|
| Gastroenterology | 1 | 1999 | 196 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 1284 | 0.010 |
Why?
|
| Echocardiography | 2 | 1996 | 1052 | 0.010 |
Why?
|
| Personnel, Hospital | 1 | 1996 | 34 | 0.010 |
Why?
|
| Pharynx | 1 | 1996 | 64 | 0.010 |
Why?
|
| Serotyping | 1 | 1996 | 178 | 0.010 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1978 | 169 | 0.010 |
Why?
|
| Intellectual Disability | 1 | 1983 | 1056 | 0.010 |
Why?
|
| Carrier State | 1 | 1996 | 77 | 0.010 |
Why?
|
| Technology, High-Cost | 1 | 1996 | 3 | 0.010 |
Why?
|
| Cerebral Ventricles | 1 | 1996 | 80 | 0.010 |
Why?
|
| Financing, Organized | 1 | 1996 | 19 | 0.010 |
Why?
|
| Parental Consent | 1 | 1996 | 23 | 0.010 |
Why?
|
| Radiography | 1 | 1998 | 821 | 0.010 |
Why?
|
| Beneficence | 1 | 1996 | 82 | 0.010 |
Why?
|
| Health Care Rationing | 1 | 1996 | 58 | 0.010 |
Why?
|
| Air | 1 | 1995 | 25 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 1996 | 361 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 1996 | 478 | 0.010 |
Why?
|
| Xanthomonas | 1 | 1994 | 5 | 0.010 |
Why?
|
| Malassezia | 1 | 1994 | 7 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1995 | 182 | 0.010 |
Why?
|
| Cardiology | 1 | 1999 | 504 | 0.010 |
Why?
|
| Family | 1 | 1996 | 563 | 0.010 |
Why?
|
| Logistic Models | 1 | 1996 | 1810 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1995 | 375 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 1994 | 460 | 0.010 |
Why?
|
| Adenoviridae Infections | 1 | 1990 | 71 | 0.010 |
Why?
|
| Herpesviridae Infections | 1 | 1990 | 142 | 0.000 |
Why?
|
| Risk | 2 | 1981 | 755 | 0.000 |
Why?
|
| Parents | 1 | 1996 | 1014 | 0.000 |
Why?
|
| Cohort Studies | 1 | 1998 | 4803 | 0.000 |
Why?
|
| Cause of Death | 1 | 1990 | 474 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1988 | 176 | 0.000 |
Why?
|
| Survival Rate | 1 | 1990 | 2045 | 0.000 |
Why?
|
| Cilastatin | 1 | 1985 | 1 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1990 | 1111 | 0.000 |
Why?
|
| Imipenem | 1 | 1985 | 9 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1988 | 777 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1985 | 342 | 0.000 |
Why?
|
| Recurrence | 1 | 1987 | 1421 | 0.000 |
Why?
|
| Kinetics | 1 | 1985 | 1323 | 0.000 |
Why?
|
| Penicillin Resistance | 1 | 1981 | 81 | 0.000 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 1981 | 90 | 0.000 |
Why?
|
| United States | 1 | 1996 | 10897 | 0.000 |
Why?
|
| Cicatrix | 1 | 1981 | 123 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1981 | 680 | 0.000 |
Why?
|
| Asphyxia Neonatorum | 1 | 1978 | 15 | 0.000 |
Why?
|
| Lactates | 1 | 1978 | 93 | 0.000 |
Why?
|
| Apgar Score | 1 | 1978 | 47 | 0.000 |
Why?
|
| Bicarbonates | 1 | 1978 | 98 | 0.000 |
Why?
|
| Acid-Base Equilibrium | 1 | 1978 | 59 | 0.000 |
Why?
|
| Umbilical Arteries | 1 | 1978 | 95 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1978 | 432 | 0.000 |
Why?
|
| Carbon Dioxide | 1 | 1978 | 274 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1981 | 1090 | 0.000 |
Why?
|
| Sepsis | 1 | 1981 | 478 | 0.000 |
Why?
|
| Cerebrovascular Circulation | 1 | 1978 | 432 | 0.000 |
Why?
|